Advanced Therapies Europe
A FreeMind Group Supported Event
Phacilitate’s Advanced Therapies Europe is paving the way for new standards in European healthcare.
Learn and Be Inspired
Advanced Therapies Europe is tailored to a European audience looking to commercialize ATMPs globally, as well as an international audience looking to understand and expand into the European market. By bringing these two groups together, new partnerships can be forged to solidify Europe as a hub for cell and gene therapy. By putting global challenges in a regional context, Advanced Therapies Europe will provide the platform to showcase the diverse array of investment opportunities to early stage biotechs. It will also be the stage for highlighting innovation in Europe to existing, established industry investors.
- Promote Europe as a hub for advanced therapies
- Promote biotechs moving across the value chain and receive tools to do so
- Hand-selected investors and suppliers for one-to-one meetings
- See the entire ecosystem across cell, gene and immuno-oncology in Europe
- Unparalleled participation from decision-makers and budget holders
- Uncover investment opportunities whilst also serving an educational purpose